Temple Lung Center | Enrolling Clinical Trials
Review Our Open Clinical Trials
Asthma
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Mediumto-High Dose Inhaled Corticosteroids (Umbriel)
NCT06932263
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma (BREADTH)
NCT07323654
COPD
NCT07051707
NCT07177339
NCT07082738
NCT07190209
NCT06961214
NCT07222410
Learn More
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD (COPD-OMA)
NCT07059091
Study Comparing the Efficacy of Dupilumab Added on to Standard of Care (SOC) Treatment vs SOC Treatment Following Hospitalization for a COPD Exacerbation (MISSION)
NCT07587658
Interstitial Lung Disease (ILD)
NCT07175038
NCT06806592
NCT06388421
PH-ILD DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
NCT06388421
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease (BEconneCTD-ILD)
NCT06572384
A Study to Test Whether BI 1819479 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)
NCT06335303
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease (BLISSc-ILD)
NCT05878717
PH-ILD Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension (MOMENTOUS)
NCT06911632
PH-ILD LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
NCT05798923
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF (ARGiNAUT)
NCT07652658
Inpatient
STimulation to Activate RespIration (STARI)
NCT06832306
Lung Cancer
Lung Transplant
Mesothelioma
Pulmonary Vascular Disease
PH-ILD DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
NCT06388421
NCT04798261
PH-COPD MK-5475-013 INSIGNIA-PH-COPD: A Study of the Efficacy and Safety of MK-5475 (an Inhaled sGC Stimulator) in Adults With PH-COPD
NCT05612035
PH-COPD The RAPID - PE Study: RESCUE Advanced Protocol for the Treatment of Pulmonary Embolism
NCT06433011
A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH) (PALM-PAH)
NCT07481981
PH-ILD LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
NCT05798923
A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH) (PALM-PAH) NCT07481981
NCT07481981
Sarcoidosis
A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
NCT05890729
A Phase 2 Study of the Safety and Efficacy of Brepocitinib in Adults With Cutaneous Sarcoidosis (BEACON)
NCT06978725
Acute Respiratory Distress Syndrome (ARDS)
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
NCT06703073

